Prashant Kohli
Chief Executive Officer chez ACASTI PHARMA INC.
Fortune : 73 148 $ au 31/03/2024
Profil
Prashant Kohli is currently the Chief Executive Officer & Director at Acasti Pharma, Inc. He previously worked as the Vice President-Commercial Operations at Grace Therapeutics LLC.
Mr. Kohli completed his undergraduate degree at Augustana College (Illinois) and holds undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/12/2023 | 21 357 ( 0,23% ) | 73 148 $ | 31/03/2024 |
Postes actifs de Prashant Kohli
| Sociétés | Poste | Début |
|---|---|---|
| ACASTI PHARMA INC. | Chief Executive Officer | 04/04/2023 |
Anciens postes connus de Prashant Kohli
| Sociétés | Poste | Fin |
|---|---|---|
Grace Therapeutics LLC
 Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Corporate Officer/Principal | 01/08/2021 |
Formation de Prashant Kohli
| Augustana College (Illinois) | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |
